Maximum Dose of Donepezil
The maximum dose of donepezil is 23 mg per day for patients with moderate to severe Alzheimer's disease, while for mild to moderate disease the maximum is 10 mg per day. 1
Dosing by Disease Severity
Mild to Moderate Alzheimer's Disease
- Starting dose: 5 mg once daily in the evening
- Maximum dose: 10 mg per day
- Titration: Increase to 10 mg only after 4-6 weeks on 5 mg 1
Moderate to Severe Alzheimer's Disease
- Starting dose: 5 mg once daily in the evening
- Maximum dose: 23 mg per day
- Titration schedule:
- Start at 5 mg for 4-6 weeks
- Increase to 10 mg for at least 3 months
- Then increase to 23 mg if tolerated 1
Evidence Supporting Higher Doses
The 23 mg dose was specifically studied in patients with moderate to severe AD who had been stable on 10 mg for at least 3 months. This higher dose demonstrated statistically significant cognitive benefits over 10 mg, with a 2.2-point greater improvement on the Severe Impairment Battery (SIB) at 24 weeks 2. The benefits were most apparent in patients with more advanced disease (MMSE 0-16), particularly affecting language, visuospatial ability, attention, and construction domains 3.
Important Caveats
The 23 mg tablet must not be split, crushed, or chewed 1. This is a sustained-release formulation designed for once-daily dosing.
Tolerability Trade-offs
Higher doses come with increased adverse events. In the pivotal trial, the 23 mg dose had higher rates of:
- Nausea (11.8% vs 3% with 10 mg)
- Vomiting (5.0% vs 0.8%)
- Diarrhea (3.2% vs 1.5%)
- Overall withdrawal rate (30.2% vs 17.9%) 2
The clinical trials consistently showed that 10 mg provided greater benefits than 5 mg across cognitive and functional measures 4, 5, though the 5 mg dose had better tolerability. For patients who cannot tolerate 10 mg, 5 mg remains a reasonable maintenance dose rather than discontinuing treatment entirely.
Administration Details
- Take once daily in the evening, just before bedtime
- Can be taken with or without food
- Available as standard tablets (5 mg, 10 mg) and sustained-release formulation (23 mg) 1